Company: IMCR
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001671927-25-000014
Chunk: 42

Company: Immunocore Holdings plc
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 42
---
 external clinical and preclinical costs26,484 10,948 15,536 141.9 %Total external R&D expenses85,604 73,716 11,888 16.1 %Internal R&D expenses:Salaries and other employee-related costs23,950 21,975 1,975 9.0 %Share-based compensation expense4,499 4,152 347 8.4 %All other internal R&D costs15,725 12,342 3,383 27.4 %U.K. R&D tax credits(4,302)(3,654)(648)17.7 %Total internal R&D expenses39,872 34,815 5,057 14.5 %Total R&D expenses$125,476 $108,531 $16,945 15.6 %

For the six months ended June 30, 2025, our R&D expenses were $125.5 million, compared to $108.5 million for the six months ended June 30, 2024. 

For the six months ended June 30, 2025, our external R&D expenses increased by $11.9 million primarily due to an increase in all other external clinical and preclinical costs of $15.5 million related to continued progress in the pipeline, primarily for our autoimmune programs, including clinical material manufacturing for anticipated Phase 1 initiation. In addition, R&D expenses incurred for our tebentafusp programs increased by $8.0 million as a result of the TEBE-AM and ATOM Phase 3 trials and purchases of drug consumables. There was a decrease of $10.6 million in expenses incurred for our PRAME programs resulting from higher costs in the six months ended June 30, 2024 due to timing of manufacturing batches and purchases of drug consumables for our clinical trials partially offset by higher costs in the six months ended June 30, 2025 due to enrollment in our PRISM-MEL-301 Phase 3 clinical trial. 

For the six months ended June 30, 2025, our internal R&D expenses increased by $5.1 million primarily due to an increase in all other internal R&D costs due to the growth of our clinical and preclinical programs.

22

Table of Contents

SG&A Expenses

For the six months ended June 30, 2025, our SG&A expenses were $83.0